MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
36.79
+0.35 (+0.96%)
At close: 4:02PM EST

36.79 0.00 (0.00%)
After hours: 5:01PM EST

Stock chart is not supported by your current browser
Previous Close36.44
Open36.66
Bid0.00 x 800
Ask0.00 x 1300
Day's Range36.45 - 36.94
52 Week Range31.68 - 63.04
Volume376,823
Avg. Volume1,110,191
Market Cap3.251B
Beta (3Y Monthly)0.83
PE Ratio (TTM)9.88
EPS (TTM)3.72
Earnings DateFeb 7, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est42.71
Trade prices are not sourced from all markets
  • Markit2 days ago

    See what the IHS Markit Score report has to say about MEDNAX Inc.

    # MEDNAX Inc ### NYSE:MD View full report here! ## Summary * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is low for MD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $5.31 billion over the last one-month into ETFs that hold MD are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire2 days ago

    MEDNAX 2018 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 7, 2019

    MEDNAX, Inc. (MD), will host an investor conference call and webcast on Thursday, February 7, 2019 at 10:00 a.m. ET, to discuss results from operations for the quarter and the twelve months ended December 31, 2018. The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors. MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.

  • Should You Be Worried About MEDNAX, Inc.’s (NYSE:MD) 11% Return On Equity?
    Simply Wall St.11 days ago

    Should You Be Worried About MEDNAX, Inc.’s (NYSE:MD) 11% Return On Equity?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...

  • Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?
    Zacks23 days ago

    Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?

    While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.

  • 6 Cheap Stocks With Growing Book Value
    GuruFocus.comlast month

    6 Cheap Stocks With Growing Book Value

    According to the GuruFocus All-In-One Screener, the following companies have grown their book value per share (BV/S) over the last decade. BV/S is calculated as total equity minus preferred stock, divided by shares outstanding. Since the BV/S may not reflect the company's true value, some investors check the tangible book value to confirm their investment ideas.

  • Business Wirelast month

    MEDNAX Announces Completion of $250 Million Accelerated Share Repurchase Program

    MEDNAX, Inc. (MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric physician services, and management services, today announced that it has completed the $250 million accelerated share repurchase (ASR) program previously announced on September 4, 2018. Under the terms of the ASR, the Company repurchased approximately 5.9 million shares of its common stock at an average price of $42.47 per share. The ASR program was completed as part of the previously announced authorization by MEDNAX’s Board of Directors to repurchase up to $500 million of the Company’s common stock.

  • Hedge Funds Aren’t Crazy About Mednax Inc. (MD) Anymore
    Insider Monkeylast month

    Hedge Funds Aren’t Crazy About Mednax Inc. (MD) Anymore

    Does Mednax Inc. (NYSE:MD) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions in profits […]

  • Here’s How P/E Ratios Can Help Us Understand MEDNAX Inc (NYSE:MD)
    Simply Wall St.last month

    Here’s How P/E Ratios Can Help Us Understand MEDNAX Inc (NYSE:MD)

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use MEDNAX Inc's (NYSE:MD) P/E ratio Read More...

  • Mednax (MD) Up 4.1% Since Last Earnings Report: Can It Continue?
    Zacks2 months ago

    Mednax (MD) Up 4.1% Since Last Earnings Report: Can It Continue?

    Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • MEDNAX and Unit Unveil Incubator for Better Patient Results
    Zacks2 months ago

    MEDNAX and Unit Unveil Incubator for Better Patient Results

    MEDNAX (MD) and its radiology arm launch MDR-AI Incubator to develop products for better patient care.

  • Business Wire2 months ago

    MEDNAX to Present at Upcoming Investor Conferences

    MEDNAX, Inc. , today announced that it is scheduled to make presentations at two upcoming investor conferences.

  • Business Wire2 months ago

    MEDNAX Radiology Solutions Launches Artificial Intelligence Incubator to Stimulate Innovation While Driving Adoption in Radiology

    MEDNAX, Inc. (MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, has launched the MEDNAX Radiology Solutions Artificial Intelligence (MDR-AI) Incubator. The MDR-AI Incubator brings together radiologists, a rich clinical dataset, and a select group of technology partners that will stimulate innovation and product development in radiology, improving radiologist’s accuracy and efficiency and overall quality of patient care. There are currently 15 active partners at various levels of engagement that are already delivering value through production use of existing models within the MEDNAX Radiology Common Imaging Platform.

  • Business Wire2 months ago

    CORRECTING and REPLACING MEDNAX Continues Its Expansion in Radiology with the Acquisition of Another Leading South Florida Radiology Practice

    Third paragraph, second sentence of release should read: In addition, the group services the Bethesda Outpatient Imaging Center at Bethesda Health City and Bethesda Health Urgent Care. MEDNAX, Inc. (MD), a leading physician services and health solutions provider, today announced the acquisition of Bethesda Radiology Associates, Inc., a private radiology physician group based in Boynton Beach, Fla. The practice will integrate with Radiology Associates of South Florida, LLC, a MEDNAX-affiliated physician practice located in Miami and serving all of South Florida.

  • Business Wire2 months ago

    MEDNAX Radiology Solutions and vRad to Exhibit at RSNA 2018 Annual Meeting Nov. 25-29

    One of the nation’s largest radiology practices, recognized as a leader in radiology, launches Artificial Intelligence Incubator and Radiology Centers of Excellence programs;

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of MD earnings conference call or presentation 1-Nov-18 2:00pm GMT

    Q3 2018 MEDNAX Inc Earnings Call

  • Business Wire2 months ago

    MEDNAX Announces Closing of $500 Million of 6.250% Senior Notes Due 2027

    MEDNAX, Inc. (MD), announced today the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The completed transaction resulted in approximately $492.5 million in net proceeds to MEDNAX, which will be used to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.

  • See what the IHS Markit Score report has to say about MEDNAX Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about MEDNAX Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Moody's2 months ago

    MEDNAX, Inc. -- Moody's assigns Ba2 rating to MEDNAX, Inc.'s new unsecured bonds

    Moody's Investors Service ("Moody's") assigned a Ba2 rating to MEDNAX, Inc.'s $750 million of new unsecured notes. There is no change to the Ba2 Corporate Family Rating, the Ba2-PD Probability of Default Rating, the Ba2 rating on the unsecured bonds due 2023, or SGL-1 Speculative Grade Liquidity Rating. Ratings assigned: MEDNAX, Inc.

  • Business Wire2 months ago

    MEDNAX Launches Private Offering of $750 Million Senior Notes Due 2026

    MEDNAX, Inc. (MD), announced today that it is proposing to issue $750.0 million aggregate amount of senior notes due 2026 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). If the offering is successfully completed, MEDNAX intends to use the net proceeds from the offering to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S. The Notes will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.

  • Business Wire2 months ago

    MEDNAX to Present at Upcoming Investor Conferences

    MEDNAX, Inc. , today announced that it is scheduled to make presentations at two upcoming investor conferences.

  • Simply Wall St.2 months ago

    Why You Should Care About MEDNAX Inc’s (NYSE:MD) Cash Levels

    If you are currently a shareholder in MEDNAX Inc (NYSE:MD), or considering investing in the stock, you need to examine how the business generates cash, and how it is reinvested. Read More...

  • MEDNAX (MD) Q3 Earnings Fall Short of Estimates, Rise Y/Y
    Zacks3 months ago

    MEDNAX (MD) Q3 Earnings Fall Short of Estimates, Rise Y/Y

    MEDNAX's (MD) Q3 earnings grow on the back of the company's operational efficiency as well as its various growth initiatives.